510(k) · Cleared

Cleared

Ena-C-T Assayed Total Cholesterol Controls

K960378510(k) TraditionalCleared Apr 3, 199668-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Actimed Laboratories, Inc. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)

Cleared on Apr 3, 1996 as substantially equivalent to K905405 (Chemtrak, Inc., 1991) after a 68-day review. Its family tree reaches back 1 generation to 1991.

Decided: Apr 3, 1996
Review: 68 days
Class: Class I
Product code: JJX
Recalls: None
Predicates: 1

Its longest line of descent runs back 1 generation to K905405 (1991). No later device cites it as a predicate yet.

By dateBy generation

Root · 1 generation backK905405 Chemtrak Accumeter Cholesterol TestChemtrak, Inc. · 1991
This deviceK960378 Ena-C-T Assayed Total Cholesterol ControlsActimed Laboratories, Inc. · 1996

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K905405	Chemtrak Accumeter Cholesterol Test	Chemtrak, Inc.	1991	—
0 (this device)	K960378	Ena-C-T Assayed Total Cholesterol Controls	Actimed Laboratories, Inc.	1996	—

FIG. 1 — Lineage of K960378, 1991–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Candidate predicates for a device like this, rankedin the report
Recall history across each candidate’s familyin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K905405	Chemtrak Accumeter Cholesterol Test Summary page 1 …Med Laboratories, Inc. 5 Terri Lane Burlington, NJ 08016 Classification Name Quality Control Material Predicate Device ChemTrak, Inc. AccuMeter® Cholesterol Controls (K905405) TPRRSE Intended Use and Indications for Use ENA-C T™ Assayed Total Cholesterol Controls are intended for exclus…	Chemtrak, Inc.	1991	—

Also cleared against K905405: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

Its one ancestor has no recall.
2 other devices also cite its predicate K905405.

How does its category compare?

All JJX devices

JJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JJX

2in 2017

2007high 24 (2010) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJX

31in 2016

2007high 80 (2009) · low 30 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJX

1in 2021

2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJX

22in 2025

2007high 82 (2019) · low 0 (2008)2025

MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	6	53	3	2
2008	8	52	3	0
2009	17	80	0	1
2010	24	80	3	6
2011	19	62	2	62
2012	15	40	0	32
2013	19	37	0	51
2014	22	30	1	48
2015	11	65	1	67
2016	6	31	2	37
2017	2	—	0	19
2018	0	—	2	35
2019	0	—	0	82
2020	0	—	0	77
2021	0	—	1	43
2022	0	—	0	24
2023	0	—	0	22
2024	0	—	0	30
2025	0	—	0	22
2026	0	—	0	—

What is it indicated for?

ENA-C T™ Assayed Total Cholesterol Controls are intended for exclusive use with the ENA.C.T™ Total Cholesterol Test to monitor the performance of the test at the medical decision points in the determination of elevated cholesterol. The ENA.C-T™ Total Cholesterol Test is an instrument-free enzymatic assay for the quantitative determination of cholesterol in fingerstick whole blood for use by physicians to screen for elevated cholesterol as a risk factor in coronary heart disease (CHD).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K960378 · printed Nov 6, 2026

Cite this page

510(k) Report. “K960378: Ena-C-T Assayed Total Cholesterol Controls.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K960378

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026